NCT02512185View on ClinicalTrials.gov

Towards Optimal Prescription of Chemotherapy in Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

206

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

April 30, 2019

Study Completion Date

December 31, 2019

Conditions
Prostate Cancer
Trial Locations (4)

L8V 5C2

Juravinski Cancer Centre, Hamilton

K7L 2V7

Kingston Health Sciences Centre -KGH, Kingston

M4N 3M5

Odette Cancer Centre, Toronto

M5G 2M9

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
collaborator

Prostate Cancer Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT02512185 - Towards Optimal Prescription of Chemotherapy in Prostate Cancer | Biotech Hunter | Biotech Hunter